Psychemedics (PMD) Short-Term Debt to Capital

The price action chart for Psychemedics (PMD) illustrates the performance of the company, which specializes in laboratory diagnostics. Its growth is driven by the precision of hair testing and long-term agreements with the public sector, where the metric stands at 0.20. The reliability of results is ensured by the secure transportation of biomaterials. Meanwhile, the business relies on corporate expenditures for personnel screening, carefully controlling costs amidst potential demand fluctuations.

This ratio determines the share of short-term liabilities within the equity structure, measuring current liquidity and default risk; by tracking the change in the ratio of short-term debt to equity, an investor assesses the efficiency of working capital management at Psychemedics (PMD) amid a shrinking market share caused by the expansion of rapid testing, where excessive debt load could become critical during revenue stagnation.